SPYRE THERAPEUTICS INC

Ticker: SYRE CUSIP: 00773J202 Class: Common Stock

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,035,074 Value ($000) $132,189 Avg Close $26.13 Range $15.86 - $35.31
Q3 2025
Shares 3,050,730 Value ($000) $51,130 Avg Close $16.31 Range $14.00 - $18.30
Q2 2025
Shares 3,066,586 Value ($000) $45,907 Avg Close $14.80 Range $10.91 - $19.20
Q1 2025
Shares 2,898,267 Value ($000) $46,764 Avg Close $20.81 Range $16.13 - $26.01
Q4 2024
Shares 2,846,473 Value ($000) $66,266 Avg Close $29.32 Range $22.37 - $40.26
Q3 2024
Shares 2,515,920 Value ($000) $73,993 Avg Close $27.85 Range $23.00 - $32.41
Q2 2024
Shares 1,911,566 Value ($000) $44,941 Avg Close $33.73 Range $22.19 - $40.84
Q1 2024
Shares 497,181 Value ($000) $18,858 Avg Close $28.97 Range $18.54 - $47.97
Q4 2023
Shares 39,446 Value ($000) $849 Avg Close $13.78 Range $8.43 - $22.66
Q3 2023
Shares 33,077 Value ($000) $405 Avg Close $13.22 Range $9.53 - $18.00